Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

TAP prodrug of duocarmycin derivative shows increased tumor specificity

Nov. 9, 2001

Antitumor activity of new VEGFR2 inhibitor under study at Boehringer Ingelheim

Nov. 9, 2001

Inhibitors of MEK potentially useful for proliferative disorders described in patent

Nov. 8, 2001

Novel cancer-related protein identified by Georgetown and NeoPharm

Nov. 8, 2001

Clinical evaluation of novel anticancer agent CT-2584 summarized at recent meeting

Nov. 8, 2001

Optimal dose and schedule of administration determined for Apomine

Nov. 8, 2001

Orally active taxane profiled at recent international cancer conference

Nov. 8, 2001

Oral pan-erbB tyrosine kinase inhibitor shows evidence of activity, good tolerance in phase I

Nov. 8, 2001

Enrollment commences in phase I/II Neoquin trial for early-stage bladder cancer

Nov. 8, 2001

Potent LHRH antagonists with improved properties patented by Zentaris

Nov. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...